{
    "title": "Remdesivir will be combined with a multiple sclerosis drug in next phase of federal tests in hopes the combination will fight deadly inflammation in coronavirus patients",
    "url": "https://www.dailymail.co.uk/health/article-8640889/Federal-study-test-combination-remdesivir-multiple-sclerosis-coronavirus-patients.html",
    "date": "2020-08-18",
    "keywords": [
        "drug",
        "remdesivir",
        "study",
        "treatment",
        "placebo",
        "phase",
        "coronavirus",
        "interferon",
        "virus",
        "combination",
        "covid19",
        "group",
        "medication",
        "sclerosis",
        "antiinflammatory",
        "immune",
        "system",
        "replication",
        "cytokine",
        "body",
        "trial",
        "beta",
        "share",
        "disease",
        "phasein",
        "institutes",
        "health",
        "percent",
        "faster",
        "recovery",
        "time",
        "york",
        "timesbeta",
        "response",
        "overreaction",
        "picturedand",
        "staff",
        "center",
        "houston",
        "texas",
        "treat",
        "patient",
        "icu",
        "july",
        "actt",
        "institute",
        "allergy",
        "medicationabout",
        "team",
        "dementia",
        "cough",
        "reveal",
        "article",
        "resultsone",
        "southampton",
        "england",
        "formulation",
        "course",
        "period",
        "kong",
        "placebothose",
        "control",
        "emergency",
        "use",
        "authorization",
        "comparison",
        "inflammation",
        "doesnt"
    ],
    "category": [
        "health"
    ]
}